Literature DB >> 33809181

In Vitro Combination Effect of Topical and Oral Anti-Onychomycosis Drugs on Trichophyton rubrum and Trichophyton interdigitale.

Keita Sugiura1, Akane Masumoto1, Haruki Tachibana1, Yoshiyuki Tatsumi1.   

Abstract

To evaluate the combination effects of anti-onychomycosis drugs, the minimum inhibitory concentrations of topical (efinaconazole, luliconazole, and tavaborole) and oral (itraconazole and terbinafine) drugs for Trichophyton rubrum and Trichophyton interdigitale (8 each, with a total of 16 strains) were determined using the microdilution checkerboard technique based on the Clinical and Laboratory Standard Institute guidelines. No antagonism was observed between the topical and oral drugs against all the tested strains. Efinaconazole with terbinafine exerted a synergistic effect on 43.8% of the strains tested (7/16 strains) and efinaconazole with itraconazole on 12.5% (2/16 strains). Conversely, luliconazole showed no synergistic effect with terbinafine but was synergistically effective with itraconazole against 31.3% of the strains (5/16 strains). Tavaborole showed no synergistic effect with terbinafine and was synergistically effective with itraconazole against 18.8% of the strains (3/16 strains). The results suggest that a combination of topical and oral drugs could be a potential clinical option for onychomycosis treatment, and overall, the efinaconazole and oral drug combination would be the most advantageous among the tested combinations.

Entities:  

Keywords:  FIC index; anti-onychomycosis drug; combination antifungal effect

Year:  2021        PMID: 33809181      PMCID: PMC7999459          DOI: 10.3390/jof7030208

Source DB:  PubMed          Journal:  J Fungi (Basel)        ISSN: 2309-608X


  30 in total

Review 1.  Combination therapy for onychomycosis.

Authors:  J H Olafsson; B Sigurgeirsson; R Baran
Journal:  Br J Dermatol       Date:  2003-09       Impact factor: 9.302

Review 2.  Improved efficacy in onychomycosis therapy.

Authors:  Aditya K Gupta; Maryse Paquet
Journal:  Clin Dermatol       Date:  2013 Sep-Oct       Impact factor: 3.541

3.  British Association of Dermatologists' guidelines for the management of onychomycosis 2014.

Authors:  M Ameen; J T Lear; V Madan; M F Mohd Mustapa; M Richardson
Journal:  Br J Dermatol       Date:  2014-11       Impact factor: 9.302

Review 4.  Pharmacokinetics of antifungal agents in onychomycoses.

Authors:  D Debruyne; A Coquerel
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

5.  Single-blind, randomized, prospective study on terbinafine and itraconazole for treatment of dermatophyte toenail onychomycosis in the elderly.

Authors:  A K Gupta; N Konnikov; C W Lynde
Journal:  J Am Acad Dermatol       Date:  2001-03       Impact factor: 11.527

6.  Prevalence and epidemiology of onychomycosis in patients visiting physicians' offices: a multicenter canadian survey of 15,000 patients.

Authors:  A K Gupta; H C Jain; C W Lynde; P Macdonald; E A Cooper; R C Summerbell
Journal:  J Am Acad Dermatol       Date:  2000-08       Impact factor: 11.527

7.  In vitro antifungal oral drug and drug-combination activity against onychomycosis causative dermatophytes.

Authors:  D A Santos; J S Hamdan
Journal:  Med Mycol       Date:  2006-06       Impact factor: 4.076

Review 8.  The rationale for combination therapy.

Authors:  E G Evans
Journal:  Br J Dermatol       Date:  2001-10       Impact factor: 9.302

9.  In vitro susceptibility of dermatomycoses agents to six antifungal drugs and evaluation by fractional inhibitory concentration index of combined effects of amorolfine and itraconazole in dermatophytes.

Authors:  Takashi Tamura; Miwa Asahara; Mikachi Yamamoto; Mariko Yamaura; Mitsuru Matsumura; Kazuo Goto; Ali Rezaei-Matehkolaei; Hossein Mirhendi; Miho Makimura; Koichi Makimura
Journal:  Microbiol Immunol       Date:  2014-01       Impact factor: 1.955

10.  Efficacy Coefficients Determined Using Nail Permeability and Antifungal Activity in Keratin-Containing Media Are Useful for Predicting Clinical Efficacies of Topical Drugs for Onychomycosis.

Authors:  Yoshiki Matsuda; Keita Sugiura; Takashi Hashimoto; Akane Ueda; Yoshihiro Konno; Yoshiyuki Tatsumi
Journal:  PLoS One       Date:  2016-07-21       Impact factor: 3.240

View more
  1 in total

1.  In Vitro Antifungal Combination of Terbinafine with Itraconazole against Isolates of Trichophyton Species.

Authors:  Anne-Laure Bidaud; Patrick Schwarz; Anuradha Chowdhary; Eric Dannaoui
Journal:  Antimicrob Agents Chemother       Date:  2021-10-11       Impact factor: 5.938

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.